{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:27:43Z","timestamp":1777418863224,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p>Synthetic cannabinoid-induced toxicity is increasing in frequency across the US, with more than 1057 reported cases as of August 2010. There is a paucity of literature on synthetic cannabinoid toxicity; however, there are various reports of adverse effects including tachycardia, hypertension, tachypnea, chest pain, heart palpitations, hallucinations, racing thoughts, and seizures. While reports suggest that toxic symptoms last no longer than 3-4 hours, with no residual adverse effects in many cases, there is concern about serious acute and long-term toxicities. This article reviews the development, abuse, toxicity, treatment, and legal status of synthetic cannabinoids. It is important for health-care professionals to recognize and appropriately treat synthetic cannabinoid-induced toxicity.<\/jats:p>","DOI":"10.1345\/aph.1p580","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T14:54:17Z","timestamp":1297868057000},"page":"414-417","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":85,"title":["The \u201cNew\u201d Marijuana"],"prefix":"10.1177","volume":"45","author":[{"given":"Daina L","family":"Wells","sequence":"first","affiliation":[{"name":"Psychiatry, Department of Mental Health, Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A","family":"Ott","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Purdue University, Indianapolis, IN; Clinical Pharmacy Specialist, Psychiatry, Wishard Health Services"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"bibr1-aph.1P580","unstructured":"Senate Committee on Public Health and Welfare. State of Kansas supplemental note on Senate Bill No. 348. Session of 2010. http:\/\/www.kslegislature.org\/supplemental\/2010\/SN0348.pdf (accessed 2010 Jun 2)."},{"key":"bibr2-aph.1P580","volume-title":"Toxicologist says K2 may cause extreme anxiety, seizures","author":"Lanham J","year":"2010"},{"key":"bibr3-aph.1P580","author":"Wehrman J","year":"2010","journal-title":"American Association of Poison Control Centers"},{"key":"bibr4-aph.1P580","unstructured":"DEA Public Affairs. DEA moves to emergency control synthetic marijuana. News from DEA, Domestic Field Divisions, Washington, DC, news releases. November 24, 2010. http:\/\/www.justice.gov\/dea\/pubs\/pressrel\/pr112410p.html (accessed 2010 Dec 7)."},{"key":"bibr5-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1002\/jms.1811"},{"key":"bibr6-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03119.x"},{"key":"bibr7-aph.1P580","author":"D'Andrea N","year":"2010","journal-title":"Phoenix New Times"},{"key":"bibr8-aph.1P580","unstructured":"Synthetic cannabinoids and \u2018Spice'. EMCDDA. Europa EU Publications. http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/synthetic-cannabinoids\/ (accessed 2010 Mar 9)."},{"key":"bibr9-aph.1P580","unstructured":"Synchronium. JWH-018, Spice & me. February 14, 2009. http:\/\/www.synchronium.net\/2009\/02\/14\/jwh-018-spice-me\/ (accessed 2010 Mar 9)."},{"key":"bibr10-aph.1P580","author":"Bryner J","year":"2010","journal-title":"Live-Science"},{"key":"bibr11-aph.1P580","unstructured":"Drugs and chemicals of concern: JWH-018* 1-pentyl-3-(1-naphthoyl)in-dole [purported ingredient of \u201cSpice\u201d]. US Department of Justice\/DEA\/Office of Diversion Control. July 2009. http:\/\/www.deadiversion.usdoj.gov\/drugs_concern\/spice\/spice_jwh018.htm\/ (accessed 2010 Mar 16)."},{"key":"bibr12-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1021\/ac900564u"},{"key":"bibr13-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2009.06.008"},{"key":"bibr14-aph.1P580","first-page":"73","volume":"42","author":"\u201cSpice\u201d - plant material(s) laced with synthetic canabinoids or cannabinoid mimicking compounds.","year":"2009","journal-title":"March"},{"key":"bibr15-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.46.120604.141254"},{"key":"bibr16-aph.1P580","unstructured":"Substance Information Network 2003\u20132009. Drugs-Forum. October 2, 2009. http:\/\/www.drugs-forum.com\/forum\/printthread.php?t=117873\/ (accessed 2010 Mar 9)."},{"key":"bibr17-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707567"},{"key":"bibr18-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4184(200212)335:9<443::AID-ARDP443>3.0.CO;2-U"},{"key":"bibr19-aph.1P580","unstructured":"Scienceblogs. http:\/\/scienceblogs.com\/terrasig\/220px-JWH-018.svg.png (accessed 2011 Feb 7)."},{"key":"bibr20-aph.1P580","unstructured":"Serotonin, http:\/\/images.wikia.com\/psychology\/images\/d\/dd\/Serotoninskeletal.png (accessed 2011 Feb 7)."},{"key":"bibr21-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-010-0517-6"},{"key":"bibr22-aph.1P580","unstructured":"Substance Information Network 2003\u20132009. Drugs-Forum. http:\/\/www.drugs-forum.com\/forum\/showthread.php?t=88133 (accessed 2010 May 24)."},{"key":"bibr23-aph.1P580","volume-title":"Doctors concerned over possible link of K2, heart damage","author":"St. James J"},{"key":"bibr24-aph.1P580","author":"Leinwand D","year":"2010","journal-title":"USA Today"},{"key":"bibr25-aph.1P580","unstructured":"Kehoe T. Prosecutor: K2 synthetic pot may already be illegal in Indiana. May 26,2010. http:\/\/www.wsbt.com\/news\/Local\/94979744.html (accessed 2010 Jun 2)."},{"key":"bibr26-aph.1P580","author":"Vitamin E","journal-title":"DRUGDEX Drug Evaluations"},{"key":"bibr27-aph.1P580","unstructured":"(BCHD10-115) Public Health Advisory\u2014evolving new drug abuse problem\u2014synthetic marijuana. Burlington County NJLINCS-HAN. February 22, 2010 (accessed 2010 May 24)."},{"key":"bibr28-aph.1P580","unstructured":"Haddad LM, Shannon MW, Winchester JF. Clinical management of poisoning and drug overdose. 3rd ed. Philadelphia, PA: WB Saunders Co., 1998: 1151."},{"key":"bibr29-aph.1P580","unstructured":"Drugs and chemicals of concern: clenbuterol. US Department of Justice\/DEA\/Office of Diversion Control. October 2009. http:\/\/wwwdeadiversion.usdoj.gov\/drugs_concern\/clenbuterol.htm (accessed 2010 Mar 16)."},{"key":"bibr30-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.6"},{"key":"bibr31-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0024-2"},{"key":"bibr32-aph.1P580","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.6.694"},{"key":"bibr33-aph.1P580","author":"Voravong S","year":"2010","journal-title":"Journal & Courier"},{"key":"bibr34-aph.1P580","unstructured":"Introductory Provisions. 21 USC Sec. 802. Chapter 13, Subchapter I, Part A. US Drug Enforcement Administration, http:\/\/www.justice.gov\/dea\/pubs\/csa\/802.htm (accessed 2010 May 24)."},{"key":"bibr35-aph.1P580","unstructured":"Tetrahydrocannabinol, www.gcdandscience.org\/images\/thc.gif (accessed 2011 Feb 7)."}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1P580","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1P580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:08:29Z","timestamp":1777374509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1P580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1345\/aph.1P580"],"URL":"https:\/\/doi.org\/10.1345\/aph.1p580","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}